Labyrinthin vaccine (Mission Therapeutics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLabyrinthin vaccine (Mission Therapeutics)
Drug Alias NameAnti-labyrinthin antibodies and vaccinesAdenocarcinoma therapies and diagnostics
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsDiagnostic imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsAdenocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMission Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMission Therapeutics
Active IndicationsN/A
Inactive IndicationsAdenocarcinoma

Other Information

ATC CodeN/A
Related LinksN/A